Bojer A, Sorensen M, Madsen S, Broadbent D, Plein S, Gaede P
Cardiovasc Diabetol. 2023; 22(1):78.
PMID: 37004049
PMC: 10067250.
DOI: 10.1186/s12933-023-01804-9.
Bojer A, Sorensen M, Vejlstrup N, Goetze J, Gaede P, Madsen P
Cardiovasc Diabetol. 2020; 19(1):184.
PMID: 33092588
PMC: 7583253.
DOI: 10.1186/s12933-020-01160-y.
Tanaka H, Tatsumi K, Matsuzoe H, Matsumoto K, Hirata K
Cardiovasc Diabetol. 2020; 19(1):84.
PMID: 32534593
PMC: 7293795.
DOI: 10.1186/s12933-020-01063-y.
Ye J, Deng G, Gao F
Drug Des Devel Ther. 2018; 12:901-909.
PMID: 29719376
PMC: 5914547.
DOI: 10.2147/DDDT.S160223.
Zhao Y, Zhang M, Tian X, Zheng L, Lu C
Int J Nanomedicine. 2016; 11:675-86.
PMID: 26937188
PMC: 4762584.
DOI: 10.2147/IJN.S99376.
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Jia G, Demarco V, Sowers J
Nat Rev Endocrinol. 2015; 12(3):144-53.
PMID: 26678809
PMC: 4753054.
DOI: 10.1038/nrendo.2015.216.
Present Insights on Cardiomyopathy in Diabetic Patients.
Felicio J, Koury C, Carvalho C, Neto J, Mileo K, Arbage T
Curr Diabetes Rev. 2015; 12(4):384-395.
PMID: 26364799
PMC: 5101638.
DOI: 10.2174/1573399812666150914120529.
Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging.
Qian C, Gong L, Yang Z, Chen W, Chen Y, Xu Z
BMC Cardiovasc Disord. 2015; 15:59.
PMID: 26113016
PMC: 4480511.
DOI: 10.1186/s12872-015-0046-9.
Thrombospondin-1: the good, the bad, and the complicated.
Ma Y, Yabluchanskiy A, Lindsey M
Circ Res. 2013; 113(12):1272-4.
PMID: 24311612
PMC: 5846086.
DOI: 10.1161/CIRCRESAHA.113.302749.
Patient selection and vitamin E treatment in diabetes mellitus.
Goldenstein H, Levy N, Lipener Y, Levy A
Expert Rev Cardiovasc Ther. 2013; 11(3):319-26.
PMID: 23469912
PMC: 3615189.
DOI: 10.1586/erc.12.187.
Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.
Mortuza R, Chakrabarti S
Heart Fail Rev. 2013; 19(1):75-86.
PMID: 23430126
DOI: 10.1007/s10741-013-9381-z.
How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.
Hirsch I, OBrien K
Diabetes Technol Ther. 2012; 14 Suppl 1:S22-32.
PMID: 22650221
PMC: 3388496.
DOI: 10.1089/dia.2012.0095.
Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.
Patel V, Bodiga S, Basu R, Das S, Wang W, Wang Z
Circ Res. 2012; 110(10):1322-35.
PMID: 22474255
PMC: 3746191.
DOI: 10.1161/CIRCRESAHA.112.268029.
Diabetic cardiomyopathy: pathophysiology and clinical features.
Miki T, Yuda S, Kouzu H, Miura T
Heart Fail Rev. 2012; 18(2):149-66.
PMID: 22453289
PMC: 3593009.
DOI: 10.1007/s10741-012-9313-3.
Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?.
Vardi M, Levy A
Curr Diab Rep. 2012; 12(3):274-9.
PMID: 22427005
PMC: 3590812.
DOI: 10.1007/s11892-012-0265-8.
Feeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-α in the heart of the offspring.
Slater-Jefferies J, Lillycrop K, Townsend P, Torrens C, Hoile S, Hanson M
J Dev Orig Health Dis. 2011; 2(4):250-5.
PMID: 22003431
PMC: 3191520.
DOI: 10.1017/S2040174410000425.
Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease.
Campbell D, Somaratne J, Jenkins A, Prior D, Yii M, Kenny J
Cardiovasc Diabetol. 2011; 10:80.
PMID: 21929744
PMC: 3182888.
DOI: 10.1186/1475-2840-10-80.
Role of various proteases in cardiac remodeling and progression of heart failure.
Muller A, Dhalla N
Heart Fail Rev. 2011; 17(3):395-409.
PMID: 21739365
DOI: 10.1007/s10741-011-9269-8.
The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults.
Shah A, Khoury P, Dolan L, Ippisch H, Urbina E, Daniels S
Diabetologia. 2010; 54(4):722-30.
PMID: 21085926
PMC: 4341988.
DOI: 10.1007/s00125-010-1974-7.
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.
Voulgari C, Papadogiannis D, Tentolouris N
Vasc Health Risk Manag. 2010; 6:883-903.
PMID: 21057575
PMC: 2964943.
DOI: 10.2147/VHRM.S11681.
